Eastwood Bio-Medical Canada Inc. (EBM.V)
Eastwood Bio-Medical Canada Inc.
4871 Shell Road
Unit 1130
Richmond, BC V6X 3Z6
Canada
604 247 2100
https://www.eleotin.ca
Sector(s): Consumer Defensive
Industry: Food Distribution
Full Time Employees:
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Youngsoo Kim | CEO & Director | 28.96k | N/A | N/A |
| Ms. Yunji Kim Esq. | President, CFO, Corporate Secretary & Director | 40.76k | N/A | 1982 |
Description
Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. It distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. The company's licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and good health; Eleotin G2000 for cardiovascular health; Eleotin H55 for sedative and tension relief; and Eleotin Zn330 for tissue formation and metabolism. Its products also include Eleotin Bentley to promote healthy glucose levels; and Eleotin LBM for hypertension relief. The company was incorporated in 2010 and is based in Richmond, Canada. Eastwood Bio-Medical Canada Inc. operates as a subsidiary of Eastwood Bio-Medical Research Inc.
Corporate Governance
Eastwood Bio-Medical Canada Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
